ArticleImmunology2025

Use of a Foamy-Virus Vector System to Produce an 'Off-the-Shelf' Fcγ-CR-T Cell Product for the Treatment of Haematological and Solid Tumour Malignancies.

Ioanna Lazana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.